Works matching IS 03125963 AND DT 2023 AND VI 62 AND IP 8
Results: 12
Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1063, doi. 10.1007/s40262-023-01284-w
- By:
- Publication type:
- Article
Authors' Reply to Lv et al.: "External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps".
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1187, doi. 10.1007/s40262-023-01272-0
- By:
- Publication type:
- Article
Comment on: "External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps".
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1183, doi. 10.1007/s40262-023-01271-1
- By:
- Publication type:
- Article
A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1169, doi. 10.1007/s40262-023-01269-9
- By:
- Publication type:
- Article
A Joint Pharmacokinetic Model for the Simultaneous Description of Plasma and Whole Blood Tacrolimus Concentrations in Kidney and Lung Transplant Recipients.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1117, doi. 10.1007/s40262-023-01259-x
- By:
- Publication type:
- Article
Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1105, doi. 10.1007/s40262-023-01265-z
- By:
- Publication type:
- Article
Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1081, doi. 10.1007/s40262-023-01252-4
- By:
- Publication type:
- Article
The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1141, doi. 10.1007/s40262-023-01261-3
- By:
- Publication type:
- Article
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1129, doi. 10.1007/s40262-023-01260-4
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor—Darolutamide.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1049, doi. 10.1007/s40262-023-01268-w
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1093, doi. 10.1007/s40262-023-01256-0
- By:
- Publication type:
- Article
Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1157, doi. 10.1007/s40262-023-01263-1
- By:
- Publication type:
- Article